<?xml version="1.0" encoding="UTF-8"?>
<document id="29112946">
	<sentence id="s1" text="In this study, we show that microRNA (protein polyubiquitination)-587 confers resistance to 5-fluorouracil (5-regulation of DNA-binding transcription factor activity)-induced apoptosis in vitro and reduces the potency of 5-FU in the inhibition of tumor growth in a mouse xenograft model in vivo.">
		<entity id="s1.e1" charOffset="38-64"
			type="GO" text="protein polyubiquitination" ontology_id="GO_0000209"/>
		<entity id="s1.e2" charOffset="87-142"
			type="GO" text="regulation of DNA-binding transcription factor activity" ontology_id="GO_0051090"/>
		<entity id="s1.e3" charOffset="224-229"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e3"
		    e2="s1.e3" pgr="false"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e3" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Knockdown of apoptotic process involved in morphogenesis expression increases AKT phosphorylation, which leads to elevated positive regulation of protein ubiquitination expression and enhanced 5-regulation of DNA-binding transcription factor activity resistance; whereas rescue of PPP2R1B expression in protein polyubiquitination-587-expressing cells decreases AKT phosphorylation/XIAP expression, re-sensitizing colon cancer cells to 5-FU-induced apoptosis.">
		<entity id="s2.e1" charOffset="13-56"
			type="GO" text="apoptotic process involved in morphogenesis" ontology_id="GO_0060561"/>
		<entity id="s2.e2" charOffset="118-173"
			type="GO" text="regulation of DNA-binding transcription factor activity" ontology_id="GO_0051090"/>
		<entity id="s2.e3" charOffset="123-168"
			type="GO" text="positive regulation of protein ubiquitination" ontology_id="GO_0031398"/>
		<entity id="s2.e4" charOffset="226-252"
			type="GO" text="protein polyubiquitination" ontology_id="GO_0000209"/>
		<entity id="s2.e5" charOffset="319-325"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e5"
		    e2="s2.e5" pgr="false"/>
		<pair id="s2.p2" e1="s2.e5"
		    e2="s2.e5" pgr="false"/>
		<pair id="s2.p3" e1="s2.e1"
		    e2="s2.e5" pgr="true"/>
		<pair id="s2.p4" e1="s2.e3"
		    e2="s2.e5" pgr="true"/>
	</sentence>
	<sentence id="s3" text="Importantly, studies of colorectal cancer specimens indicate that the expression of protein polyubiquitination-587 and apoptotic process involved in morphogenesis positively and inversely correlates with chemoresistance, respectively, in colorectal cancer.">
		<entity id="s3.e1" charOffset="35-41"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s3.e2" charOffset="84-110"
			type="GO" text="protein polyubiquitination" ontology_id="GO_0000209"/>
		<entity id="s3.e3" charOffset="119-162"
			type="GO" text="apoptotic process involved in morphogenesis" ontology_id="GO_0060561"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
		<pair id="s3.p2" e1="s3.e1"
		    e2="s3.e3" pgr="true"/>
	</sentence>
	<sentence id="s4" text="These findings indicate that the protein polyubiquitination-587/apoptotic process involved in morphogenesis/pAKT/positive regulation of protein ubiquitination signaling axis has an important role in mediating response to chemotherapy in colorectal cancer.">
		<entity id="s4.e1" charOffset="33-59"
			type="GO" text="protein polyubiquitination" ontology_id="GO_0000209"/>
		<entity id="s4.e2" charOffset="64-107"
			type="GO" text="apoptotic process involved in morphogenesis" ontology_id="GO_0060561"/>
		<entity id="s4.e3" charOffset="113-158"
			type="GO" text="positive regulation of protein ubiquitination" ontology_id="GO_0031398"/>
		<entity id="s4.e4" charOffset="171-177"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e4" pgr="false"/>
		<pair id="s4.p2" e1="s4.e2"
		    e2="s4.e4" pgr="true"/>
		<pair id="s4.p3" e1="s4.e3"
		    e2="s4.e4" pgr="true"/>
	</sentence>
	<sentence id="s5" text="A major implication of our study is that inhibition of protein polyubiquitination-587 or restoration of apoptotic process involved in morphogenesis expression may have significant therapeutic potential to overcome drug resistance in colorectal cancer patients and that the combined use of an AKT inhibitor with 5-regulation of DNA-binding transcription factor activity may increase efficacy in colorectal cancer treatment">
		<entity id="s5.e1" charOffset="55-81"
			type="GO" text="protein polyubiquitination" ontology_id="GO_0000209"/>
		<entity id="s5.e2" charOffset="104-147"
			type="GO" text="apoptotic process involved in morphogenesis" ontology_id="GO_0060561"/>
		<entity id="s5.e3" charOffset="185-191"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s5.e4" charOffset="254-309"
			type="GO" text="regulation of DNA-binding transcription factor activity" ontology_id="GO_0051090"/>
		<pair id="s5.p1" e1="s5.e3"
		    e2="s5.e4" pgr="false"/>
		<pair id="s5.p2" e1="s5.e1"
		    e2="s5.e3" pgr="false"/>
		<pair id="s5.p3" e1="s5.e2"
		    e2="s5.e3" pgr="true"/>
	</sentence>
</document>
